Documentos relacionados

1. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.
2. Characteristics and progression-free survival of Afro-Caribbean men with metastatic hormone-sensitive prostate cancer at the time of diagnosis.
3. Spine metastasis in patients with prostate cancer: Survival prognosis assessment.
4. Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.
5. The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland.
6. A Pilot Study of F-18 Fluciclovine-PET/CT as a Diagnostic Tool for Bone Metastases in Patients With Castrate Resistant Prostate Adenocarcinoma and Correlative Analysis of Blood and Bone Molecular Testing (The FACT Study).
7. The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression.
8. The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.
9. The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.
10. Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.